The DOI matches its Crossref record; 70 of the 73 references it cites were found in a registry or an index.
Acetyl-CoA Synthetase 2 Promotes Acetate Utilization and Maintains Cancer Cell Growth under Metabolic Stress
Open accessAbstract
A functional genomics study revealed that the activity of acetyl-CoA synthetase 2 (ACSS2) contributes to cancer cell growth under low-oxygen and lipid-depleted conditions. Comparative metabolomics and lipidomics demonstrated that acetate is used as a nutritional source by cancer cells in an ACSS2-dependent manner, and supplied a significant fraction of the carbon within the fatty acid and phospholipid pools. ACSS2 expression is upregulated under metabolically stressed conditions and ACSS2 silencing reduced the growth of tumor xenografts. ACSS2 exhibits copy-number gain in human breast tumors, and ACSS2 expression correlates with disease progression. These results signify a critical role for acetate consumption in the production of lipid biomass within the harsh tumor microenvironment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Some cancers are nevertheless dependent on expression of acetyl-CoA synthetase 2 (ACSS2), the cytosolic enzyme that allows cells to synthesize acetyl-CoA from acetate, making this represents a potential therapeutic target (Comerford et al., 2014; Schug et al., 2015).”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Schug et al., 2015
In the citing paper
“In cancer cells, citrate becomes labeled following supplementation of cells with isotopically labeled acetate ([13C]acetate), indicating that acetate can undergo oxidation in the TCA cycle in cultured cell lines (69).”
From Regulation and function of the mammalian tricarboxylic acid cycle (2023) · cites this paper as [69]
In the citing paper
“Finally, extracellular acetate has recently been shown to be utilized by some cancers as a source of acetyl-CoA for biosynthesis.”
From The emerging hallmarks of cancer metabolism (2016) · cites this paper as Schug et al., 2015
In the citing paper
“Specifically, a variety of tumor types localized to the brain, including primary glioblastomas as well as brain metastases that originated from other tissues, have been shown to assimilate exogenous acetate and incorporate acetate-derived carbons into de novo synthesized fatty acids (Comerford et al., 2014; Mashimo et al., 2014; Schug et al., 2015).”
From The emerging hallmarks of cancer metabolism (2016) · cites this paper as Schug et al., 2015
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A. A., Kim, S., Wilson, C. J., Lehár, J., Kryukov, G. V., Sonkin, D., et al. (2012) · Nature · doi:10.1038/nature11003 · Cited by 7,950
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
METABRIC Group, Curtis, C., Shah, S. P., Chin, S.-F., Turashvili, G., Rueda, O. M., Dunning, M. J., Speed, D., Lynch, A. G., Samarajiwa, S., et al. (2012) · Nature · doi:10.1038/nature10983 · Cited by 6,097
Kim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
Menendez, J. A., & Lupu, R. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2222 · Cited by 2,941
COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer
Forbes, S. A., Bindal, N., Bamford, S., Cole, C., Kok, C. Y., Beare, D., Jia, M., Shepherd, R., Leung, K., Menzies, A., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq929 · Cited by 2,278
HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption
Papandreou, I., Cairns, R. A., Fontana, L., Lim, A. L., & Denko, N. C. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.012 · Cited by 2,267
Pinkel, D., Segraves, R., Sudar, D., Clark, S. M., Poole, I., Kowbel, D., Collins, C. C., Kuo, W.-L., Chen, C., Zhai, Y., et al. (1998) · Nature Genetics · doi:10.1038/2524 · Cited by 2,238
Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia
Metallo, C. M., Gameiro, P. A., Bell, E. L., Mattaini, K. R., Yang, J., Hiller, K., Jewell, C. M., Johnson, Z. R., Irvine, D. J., Guarente, L., et al. (2012) · Nature · doi:10.1038/nature10602 · Cited by 1,791
Kimura, I., Ozawa, K., Inoue, D., Imamura, T., Kimura, K., Maeda, T., Terasawa, K., Kashihara, D., Hirano, K., Tani, T., et al. (2013) · Nature Communications · doi:10.1038/ncomms2852 · Cited by 1,512
SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth
Porstmann, T., Santos, C. R., Griffiths, B., Cully, M., Wu, M., Leevers, S., Griffiths, J. R., Chung, Y.-L., & Schulze, A. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.07.007 · Cited by 1,413
Self-citation
Flagged first, then by citations
3 of the 73 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 301–400 of 818
Park, G. S. H., Jung, S., Wellen, K. E., & Jang, C. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00614-x · Cited by 37
Wang, R., Wang, J., Liu, M., Strappe, P., Li, M., Wang, A., Zhuang, M., Liu, J., BLANCHARD, C. L., & Zhou, Z. (2022) · Food Hydrocolloids · doi:10.1016/j.foodhyd.2022.107556 · Cited by 37
Lv, Y., Guo, X., & Gui, Y. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000487293 · Cited by 37
Zheng, C., Lü, F., Chen, B., Yang, J., Yu, H., Wang, D., Xie, H., Chen, K., Xie, Y., Li, J., et al. (2023) · Cancer Science · doi:10.1111/cas.15983 · Cited by 36
Lipid Regulatory Proteins as Potential Therapeutic Targets for Ovarian Cancer in Obese Women
Yang, J., & Stack, M. S. (2020) · Cancers · doi:10.3390/cancers12113469 · Cited by 35
Yenilmez, B., Kelly, M., Zhang, G., Wetoska, N., Ilkayeva, O., Min, K., Rowland, L. A., DiMarzio, C., He, W., Raymond, N., et al. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102401 · Cited by 36
The role of Her2 and other oncogenes of the PI3K/AKT pathway in mitochondria
Rohlenová, K., Neužil, J., & Rohlena, J. (2016) · Biological Chemistry · doi:10.1515/hsz-2016-0130 · Cited by 34
microRNA-29 mediates a novel negative feedback loop to regulate SCAP/SREBP-1 and lipid metabolism
Ru, P., & Guo, D. (2017) · RNA & DISEASE · doi:10.14800/rd.1525 · Cited by 34
Volatilomic insight of head and neck cancer via the effects observed on saliva metabolites
Taware, R., Taunk, K., Pereira, J. A. M., Shirolkar, A. R., Soneji, D., Câmara, J. S., Nagarajaram, H. A., & Rapole, S. (2018) · Scientific Reports · doi:10.1038/s41598-018-35854-x · Cited by 34
Linden, C. V., & Corbet, C. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.05.016 · Cited by 34
C/EBPδ-Slug-Lox1 axis promotes metastasis of lung adenocarcinoma via oxLDL uptake
Wang, D., Cheng, X., Li, Y., Guo, M., Zhao, W., Qiu, J., Zheng, Y. F., Meng, M., Ping, X., Chen, X., et al. (2019) · Oncogene · doi:10.1038/s41388-019-1015-z · Cited by 34
De Novo Lipogenesis as a Source of Second Messengers in Adipocytes
Hsiao, W., & Guertin, D. A. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1264-9 · Cited by 36
Hernandez‐Sanabria, E., Heiremans, E., Calatayud, M., Props, R., Leclercq, L., Snoeys, J., & de Wiele, T. V. (2020) · npj Biofilms and Microbiomes · doi:10.1038/s41522-020-0119-0 · Cited by 35
Metabolic therapy and bioenergetic analysis: The missing piece of the puzzle
Duraj, T., Carrión-Navarro, J., Seyfried, T. N., Garcia‐Romero, N., & Ayuso‐Sacido, Á. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101389 · Cited by 36
Metabolic stress induces GD2+ cancer stem cell-like phenotype in triple-negative breast cancer
Jaggupilli, A., Ly, S., Nguyen, K., Anand, V., Yuan, B., El-Dana, F., Yan, Y., Arvanitis, Z., Piyarathna, D. W. B., Putluri, N., et al. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01636-y · Cited by 35
Acetyl-CoA Synthetase 2 as a Therapeutic Target in Tumor Metabolism
Liu, M., Liu, N., Wang, J., Fu, S., Wang, X., & Chen, D. (2022) · Cancers · doi:10.3390/cancers14122896 · Cited by 39
Association between human blood metabolome and the risk of breast cancer
Wang, Y., Liu, F., Sun, L., Jia, Y., Yang, P., Guo, D., Shi, M., Wang, A., Chen, G.-C., Zhang, Y., et al. (2023) · Breast Cancer Research · doi:10.1186/s13058-023-01609-4 · Cited by 33
Targeting dysregulated lipid metabolism in the tumor microenvironment
Kim, D., Song, N., & Yim, H. (2023) · Archives of Pharmacal Research · doi:10.1007/s12272-023-01473-y · Cited by 38
Lipid Metabolism in Breast Cancer: From Basic Research to Clinical Application
Huang, X., Liu, B., & Shen, S. (2025) · Cancers · doi:10.3390/cancers17040650 · Cited by 34
Altered Mitochondrial Signalling and Metabolism in Cancer
Chattopadhyay, E., & Roy, B. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00043 · Cited by 36
Fung, A. A., Hoang, K., Zha, H., Chen, D., Zhang, W., & Shi, L. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.858017 · Cited by 29
Targeting Mitochondria with ClpP Agonists as a Novel Therapeutic Opportunity in Breast Cancer
Wedam, R., Greer, Y. E., Wisniewski, D. J., Weltz, S., Kundu, M., Voeller, D. M., & Lipkowitz, S. (2023) · Cancers · doi:10.3390/cancers15071936 · Cited by 36
Kapoore, R. V., Coyle, R., Staton, C. A., Brown, N. J., & Vaidyanathan, S. (2015) · Metabolomics · doi:10.1007/s11306-015-0833-4 · Cited by 33
Li, A. M., & Ye, J. (2023) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-062822-120857 · Cited by 31
Hlavaty, S. I., Salcido, K., Pniewski, K. A., Mukha, D., Ma, W., Kannan, T., Cassel, J. A., Srikanth, Y. V. V., Liu, Q., Kossenkov, A. V., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114988 · Cited by 32
Self-citationLi, W., Han, J., Huang, B., Xu, T., Wan, Y., Luo, D., Kong, W., Yu, Y. H., Zhang, L., Nian, Y., et al. (2025) · The EMBO Journal · doi:10.1038/s44318-025-00369-5 · Cited by 39
Disallowance of Acot7 in β-Cells Is Required for Normal Glucose Tolerance and Insulin Secretion
Martínez-Sánchez, A., Pullen, T. J., CHABOSSEAU, P. L., Zhang, Q., Haythorne, E., Cane, M. C., Nguyen‐Tu, M., Sayers, S. R., & Rutter, G. A. (2016) · Diabetes · doi:10.2337/db15-1240 · Cited by 32
Self-citationMetabolic Reprogramming and Oncogenesis
Costa, A. S. H., & Frezza, C. (2017) · International review of cytology · doi:10.1016/bs.ircmb.2017.01.001 · Cited by 32
Window of opportunity clinical trial designs to study cancer metabolism
Aroldi, F., & Lord, S. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0621-4 · Cited by 32
The metabolic landscape of urological cancers: New therapeutic perspectives
Miranda‐Gonçalves, V., Lameirinhas, A., Henrique, R., Baltazar, F., & Jerónimo, C. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.02.034 · Cited by 33
García‐Cañaveras, J. C., & Lahoz, A. (2021) · Cancers · doi:10.3390/cancers13133230 · Cited by 33
Metabolic Reprogramming Helps to Define Different Metastatic Tropisms in Colorectal Cancer
Montero‐Calle, A., de Cedrón, M. G., Quijada‐Freire, A., Solís‐Fernández, G., López-Alonso, V., Espinosa‐Salinas, I., Peláez‐García, A., Fernández‐Aceñero, M. J., de Molina, A. R., & Barderas, R. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.903033 · Cited by 33
Bezawork‐Geleta, A., Dimou, J., & Watt, M. J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1085034 · Cited by 31
Mallick, R., Bhowmik, P., & Duttaroy, A. K. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115591 · Cited by 35
Fatty acid synthase ( FASN ) signalome: A molecular guide for precision oncology
Menéndez, J. A., Cuyàs, E., Encinar, J. A., Steen, T. V., Verdura, S., Llop‐Hernández, À., López, J., Serrano‐Hervás, E., Osuna, S., Martín-Castillo, B., et al. (2023) · Molecular Oncology · doi:10.1002/1878-0261.13582 · Cited by 41
Zhang, S., He, J., Jia, Z., Yan, Z., & Yang, J. (2018) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2018.01.013 · Cited by 31
Toxico‐Metabolomics of Engineered Nanomaterials: Progress and Challenges
Ahmad, F., Wang, X., & Li, W. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201904268 · Cited by 31
Yang, X., Shao, F., Shi, S., Feng, X., Wang, W., Wang, Y., Guo, W., Wang, J., Gao, S., Gao, Y., et al. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01123 · Cited by 31
Bruzzone, C., Loizaga‐Iriarte, A., Sánchez‐Mosquera, P., Gil‐Redondo, R., Astobiza, I., Diercks, T., Cortázar, A. R., Ugalde‐Olano, A., Schäfer, H., Blanco, F. J., et al. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00091 · Cited by 31
Moonlighting Metabolic Enzymes in Cancer: New Perspectives on the Redox Code
Jiang, J., Peng, L., Wang, K., & Huang, C. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8123 · Cited by 31
Lee, H. Y., Itahana, Y., Schüchner, S., Fukuda, M., Je, H. S., Ogris, E., Virshup, D. M., & Itahana, K. (2018) · Science Signaling · doi:10.1126/scisignal.aam7893 · Cited by 31
Shedd, S. F., Lutz, N. W., & Hull, W. E. (1993) · NMR in Biomedicine · doi:10.1002/nbm.1940060405 · Cited by 31
Rodríguez‐Enríquez, S., Robledo‐Cadena, D. X., Gallardo‐Pérez, J. C., Pacheco-Velázquez, S. C., Vázquez, C., Saavedra, E., Vargas-Navarro, J. L., Blanco-Carpintero, B. A., Marín‐Hernández, Á., Jasso‐Chávez, R., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.697408 · Cited by 31
Anderson, R. G., Pladna, K. M., Schramm, N. J., Wheeler, F. B., Kridel, S. J., & Pardee, T. S. (2023) · Cancers · doi:10.3390/cancers15020484 · Cited by 29
A Molecular Voyage: Multiomics Insights into Circulating Tumor Cells
Zhang, Y. W., Gvozdenovic, A., & Aceto, N. (2024) · Cancer Discovery · doi:10.1158/2159-8290.cd-24-0218 · Cited by 31
Race, the microbiome and colorectal cancer
Royston, K. J., Adedokun, B., & Olopade, O. I. (2019) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v11.i10.773 · Cited by 30
Kenny, L. M. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.157958 · Cited by 30
Generation and characterization of monoclonal antibodies specific to Coenzyme A
Malanchuk, O., Panasyuk, G., Serbin, N. M., Gout, I. T., & Filonenko, V. V. (2015) · Biopolymers and Cell · doi:10.7124/bc.0008df · Cited by 30
Lipid metabolism dynamics in cancer stem cells: potential targets for cancers
Du, J., & Qin, H. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1367981 · Cited by 31
New perspective toward nutritional support for malnourished cancer patients: Role of lipids
Wang, Y., Zhang, T., Liu, R., Chang, M., Wei, W., Jin, Q., & Wang, X. (2021) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12706 · Cited by 30
Protein Acetylation at the Interface of Genetics, Epigenetics and Environment in Cancer
Harachi, M., Masui, K., Cavenee, W. K., Mischel, P. S., & Shibata, N. (2021) · Metabolites · doi:10.3390/metabo11040216 · Cited by 29
Jiang, L., Lee, S. C., & Ng, T. C. (2018) · Journal of Proteome Research · doi:10.1021/acs.jproteome.7b00859 · Cited by 29
A rapid method for quantifying free and bound acetate based on alkylation and GC-MS analysis
Tumanov, S., Bulusu, V., Gottlieb, E., & Kamphorst, J. J. (2016) · Cancer & Metabolism · doi:10.1186/s40170-016-0157-5 · Cited by 29
Self-citationCauses and Consequences of A Glutamine Induced Normoxic HIF1 Activity for the Tumor Metabolism
Kappler, M., Pabst, U., Weinholdt, C., Taubert, H. W., Rot, S., Kaune, T., Kotrba, J., Porsch, M., Güttler, A., Bache, M., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194742 · Cited by 29
Trefely, S., Liu, J., Huber, K., Doan, M. T., Jiang, H., Singh, J. P., von Krusenstiern, E. V., Bostwick, A., Xu, P. J., Bogner‐Strauß, J. G., et al. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.09.004 · Cited by 28
Calhoun, S., Duan, L., & Maki, C. G. (2022) · Translational Oncology · doi:10.1016/j.tranon.2022.101386 · Cited by 28
Vilaplana‐Lopera, N., Cuminetti, V., Almaghrabi, R. O. M., Papatzikas, G., Rout, A. K., Jeeves, M., González, E., Alyahyawi, Y., Cunningham, A., Erdem, A., et al. (2022) · eLife · doi:10.7554/elife.75908 · Cited by 28
A review on the role of fatty acids in colorectal cancer progression
Hoxha, M., & Zappacosta, B. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1032806 · Cited by 29
13C MRS and LC–MS Flux Analysis of Tumor Intermediary Metabolism
Shestov, A. A., Lee, S., Nath, K., Guo, L., NELSON, D. S., Roman, J. C., Leeper, D. B., Wasik, M. A., Blair, I. A., & Glickson, J. D. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00135 · Cited by 28
Zhang, J., Baddoo, M., Han, C., Strong, M. J., Cvitanovic, J., Moroz, K., Dash, S., Flemington, E. K., & Wu, T. (2016) · Oncotarget · doi:10.18632/oncotarget.10249 · Cited by 29
Differential receptor dependencies
Baig, A. M., Khan, N. A., Effendi, V., Rana, Z., Ahmad, H. R., & Abbas, F. (2016) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000432 · Cited by 28
Glucose-sensitive acetylation of Seryl tRNA synthetase regulates lipid synthesis in breast cancer
Zhao, J., Bai, H., Li, X., Yan, J., Zou, G., Wang, L., Li, X., Liu, Z., Xiang, R., Yang, X.-L., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00714-0 · Cited by 27
Li, M., Wu, X., Jing, W.-Q., Hou, W.-K., Hu, S. C., & Yan, W. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06017-2 · Cited by 28
Xu, G., Quan, S., Schell, J. R., Gao, Y., Varmazyad, M., Sreenivas, P., Cruz, D., Jiang, H., Pan, M., Han, X., et al. (2024) · Science Advances · doi:10.1126/sciadv.adj5942 · Cited by 30
Lee, H., Park, S., Lee, J. W., Lee, C., Kang, H., Kang, J., Lee, J. S., Shin, E., Youn, H., & Youn, B. (2025) · Cellular Oncology · doi:10.1007/s13402-025-01081-6 · Cited by 31
Metformin Decouples Phospholipid Metabolism in Breast Cancer Cells
Smith, T., & Phyu, S. M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151179 · Cited by 27
Maaß, C., Dallas, M. R., LaBarge, M. E., Shockley, M., Valdez, J., Geishecker, E., Stokes, C. L., Griffith, L. G., & Cirit, M. (2018) · Scientific Reports · doi:10.1038/s41598-018-25971-y · Cited by 26
Jones, D. T., Valli, A., Haider, S. A., Zhang, Q., Smethurst, E. A., Schug, Z. T., Peck, B., Aboagye, E. O., Critchlow, S. E., Schulze, A., et al. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0857 · Cited by 26
Self-citationLupien, L. E., Dunkley, E. M., Maloy, M. J., Lehner, I. B., Foisey, M. G., Ouellette, M. E., Lewis, L. D., Pooler, D. B., Kinlaw, W. B., & Baures, P. W. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.258947 · Cited by 27
Fu, J., Hu, F., Ma, T., Zhao, W., Tian, H., Zhang, Y., Hu, M., Zhou, J., Zhang, Y., Jian, C., et al. (2021) · Hepatology · doi:10.1002/hep.32126 · Cited by 27
Gut Microbiota: A Potential Target for Cancer Interventions
Zhou, H., Yuan, Y., Wang, H., Xiang, W., Li, S., Zheng, H., Wen, Y., Yang, M., Chen, L., & Zhou, J. (2021) · Cancer Management and Research · doi:10.2147/cmar.s328249 · Cited by 27
Nutritional Epigenetics in Cancer
Barrero, M. J., Cejas, P., Long, H. W., & de Molina, A. R. (2022) · Advances in Nutrition · doi:10.1093/advances/nmac039 · Cited by 27
Ilagan, Y., Mamillapalli, R., Goetz, T. G., Kayani, J., & Taylor, H. S. (2017) · Reproductive Toxicology · doi:10.1016/j.reprotox.2017.05.001 · Cited by 27
Acetyl-CoA: an interplay between metabolism and epigenetics in cancer
Hao, Y., Yi, Q., XiaoWu, X., WeiBo, C., GuangChen, Z., & XueMin, C. (2022) · Frontiers in Molecular Medicine · doi:10.3389/fmmed.2022.1044585 · Cited by 26
Serine starvation silences estrogen receptor signaling through histone hypoacetylation
Li, A. M., He, B., Karagiannis, D., Li, Y., Jiang, H., Srinivasan, P., Ramirez, Y., Zhou, M.-N., Curtis, C. N., Gruber, J. J., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2302489120 · Cited by 27
ACSS2 controls PPARγ activity homeostasis to potentiate adipose-tissue plasticity
Chen, N., Zhao, M., Wu, N., Guo, Y., Cao, B., Zhan, B., Li, Y., Zhou, T., Zhu, F., Guo, C. H., et al. (2024) · Cell Death and Differentiation · doi:10.1038/s41418-024-01262-0 · Cited by 29
FilamentID reveals the composition and function of metabolic enzyme polymers during gametogenesis
Hugener, J., Xu, J., Wettstein, R., Ioannidi, L., Velikov, D., Wollweber, F., Henggeler, A., Matos, J., & Pilhofer, M. (2024) · Cell · doi:10.1016/j.cell.2024.04.026 · Cited by 26
Metabolism and epigenetics: drivers of tumor cell plasticity and treatment outcomes
Gantner, B. N., Palma, F. R., Pandkar, M. R., Sakiyama, M. J., Arango, D., DeNicola, G. M., Gomes, A. P., & Bonini, M. G. (2024) · Trends in cancer · doi:10.1016/j.trecan.2024.08.005 · Cited by 29
Restriction of drug transport by the tumor environment
Nandigama, R., Upcin, B., Aktas, B. H., Ergün, S., & Henke, E. (2018) · Histochemistry and Cell Biology · doi:10.1007/s00418-018-1744-z · Cited by 28
Cancer cell lipid class homeostasis is altered under nutrient-deprivation but stable under hypoxia
Lisec, J., Jaeger, C., Rashid, R., Munir, R., & Zaidi, N. (2019) · BMC Cancer · doi:10.1186/s12885-019-5733-y · Cited by 27
Brain metastasis models: What should we aim to achieve better treatments?
Masmudi‐Martín, M., Zhu, L., Sánchez‐Navarro, M., Priego, N., Casanova-Acebes, M., Ruiz‐Rodado, V., Giralt, E., & Valiente, M. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.12.002 · Cited by 27
Cui, M., Yi, X., Zhu, D., & Wu, J. (2021) · Translational Cancer Research · doi:10.21037/tcr-21-655 · Cited by 29
Aria, H., Rezaei, M., Nazem, S., Daraei, A., Nikfar, G., Mansoori, B., Bahmanyar, M., Tavassoli, A., Vakil, M. K., & Mansoori, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.947885 · Cited by 26
Li, W., Deng, M., Gong, J., Hou, Y., & Zhao, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065536 · Cited by 27
The Various Metabolic Sources of Histone Acetylation
Sebastián, C., & Mostoslavsky, R. (2016) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2016.11.001 · Cited by 26
Gopal, U., & Pizzo, S. V. (2017) · Oncotarget · doi:10.18632/oncotarget.22431 · Cited by 28
Gao, J., Guo, Z., Cheng, J., Sun, B. H., Yang, J., Li, H., Wu, S., Dong, F., & Yan, X. (2020) · Scientific Reports · doi:10.1038/s41598-020-78955-2 · Cited by 29
Pathophysiological Integration of Metabolic Reprogramming in Breast Cancer
Corchado‐Cobos, R., García‐Sancha, N., Mendiburu‐Eliçabe, M., Gómez-Vecino, A., Jiménez‐Navas, A., Pérez‐Baena, M. J., Holgado-Madruga, M., Mao, J., Cañueto, J., Castillo‐Lluva, S., et al. (2022) · Cancers · doi:10.3390/cancers14020322 · Cited by 27
Azam, A., & Sounni, N. E. (2022) · Cancers · doi:10.3390/cancers14246267 · Cited by 25
Cooke, J. P., & Lai, L. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115118 · Cited by 25
Metabolic Intermediates in Tumorigenesis and Progression
He, Y., Gao, M., Tang, H., Cao, Y., Liu, S., & Tao, Y. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.33496 · Cited by 25
Metabolic Escape Routes of Cancer Stem Cells and Therapeutic Opportunities
Turdo, A., Porcelli, G., D’Accardo, C., Franco, S. D., Verona, F., Forte, S., Giuffrida, D., Memeo, L., Todaro, M., & Stassi, G. (2020) · Cancers · doi:10.3390/cancers12061436 · Cited by 27
Metabolism in the Tumor Microenvironment
Montenegro, F., & Indraccolo, S. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-44518-8_1 · Cited by 26
Lipid Metabolism as a Potential Target of Liver Cancer
Wu, K., & Lin, F. (2024) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s450423 · Cited by 27
Pommier, A., Farren, M. R., Patel, B., Wappett, M., Michopoulos, F., Smith, N. R., Kendrew, J., Frith, J., Huby, R. D. J., Eberlein, C. A., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.10.015 · Cited by 25
Self-citationPeck, B., Bland, P. J., Mavrommati, I., Muirhead, G., Cottom, H., Wai, P. T., Maguire, S. L., Barker, H. E., Morrison, E., Kriplani, D., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-1822 · Cited by 24
Self-citationMetabolic switch in cancer – Survival of the fittest
Raskov, H., Gaggar, S., Tajik, A., Orhan, A., & Gögenür, I. (2022) · European Journal of Cancer · doi:10.1016/j.ejca.2022.11.025 · Cited by 26
Selective and brain-penetrant ACSS2 inhibitors target breast cancer brain metastatic cells
Esquea, E. M., Ciraku, L., Young, R. G., Merzy, J., Talarico, A. N., Ahmed, N. N., Karuppiah, M., Ramesh, A., Chatoff, A. G., Crispim, C. V. D. S., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1394685 · Cited by 24
Brody, L., Sahuri-Arisoylu, M., Parkinson, J. R. C., Parkes, H. G., So, P., Hajji, N., Thomas, E. L., Frost, G. S., Miller, A. D., & Bell, J. D. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s135968 · Cited by 24
Shah, A., Melhuish, T. A., Fox, T. E., Frierson, H. F., & Wotton, D. (2019) · Genes & Development · doi:10.1101/gad.320127.118 · Cited by 23
Metadata
- Authors
- Schug, Z. T., Peck, B., Jones, D. T., Zhang, Q., Grosskurth, S., Alam, I. S., Goodwin, L. M., Smethurst, E., Mason, S., Blyth, K., McGarry, L., James, D., Shanks, E., Kalna, G., Saunders, R. E., Jiang, M., Howell, M., Lassailly, F., Thin, M. Z., Spencer-Dene, B., Stamp, G., van den Broek, N. J. F., Mackay, G., Bulusu, V., Kamphorst, J. J., Tardito, S., Strachan, D., Harris, A. L., Aboagye, E. O., Critchlow, S. E., Wakelam, M. J. O., Schulze, A., & Gottlieb, E.
- Affiliations
- Cancer Research UK Scotland Institute (GB)
- Cancer Research UK (GB)
- John Radcliffe Hospital (GB)
- Babraham Institute (GB)
- AstraZeneca (United Kingdom) (GB)
- Hammersmith Hospital (GB)
- University of Glasgow (GB)
- Corresponding author
- Gottlieb, Eyal
- ORCID
- Schug, Zachary T.
- Peck, Barrie
- Smethurst, Elizabeth
- Mason, Susan
- Blyth, Karen
- McGarry, Lynn
- James, Daniel
- Shanks, Emma
- Jiang, Ming
- Howell, Michael
- Thin, May Zaw
- Stamp, Gordon
- Mackay, Gillian
- Bulusu, Vinay
- Kamphorst, Jurre J.
- Tardito, Saverio
- Strachan, David
- Harris, Adrian L.
- Aboagye, Eric O.
- Critchlow, Susan E.
- Wakelam, Michael J.O.
- Schulze, Almut
- Gottlieb, Eyal
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2015-01
- Volume
- 27
- Issue
- 1
- Pages
- 57-71
- ISSN
- 1535-6108 (ISSN-L)
- PMC
- PMC4297291
- OpenAlex
- W2044515618
- Cited by
- 820
- References
- 73
- Citations by year
- 2026: 64 · 2025: 76 · 2024: 96 · 2023: 72 · 2022: 88 · 2021: 75 · 2020: 63 · 2019: 67 · 2018: 68 · 2017: 57 · 2016: 63 · 2015: 28
- FWCI
- 23.79
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Cancer Cell (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion)
- Funders
- AstraZeneca
- Francis Crick Institute (10009, 10008)
- Cancer Research UK (11359, 18278, 12011, 10337, 16466, 16584, 22311, 18974)
- National Institute for Health and Care Research (NIHR/CS/009/009, NF-SI-0611-10163, EME/13/122/01)
- Directorate for Biological Sciences
- Medical Research Council (MR/J007986/1)
- Biotechnology and Biological Sciences Research Council (BBS/E/B/000C0415, BBS/E/B/000C0413)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- acetyl-CoA synthetase 2, ACSS2, acetate utilization, cancer cell growth, metabolic stress, hypoxia, lipid depletion, tumor xenografts, fatty acid synthesis, phospholipid synthesis, tumor microenvironment, breast cancer, copy number gain, tumor progression
- MeSH terms
- Acetate-CoA Ligase, Animals, Hypoxia, Fatty Acids, Humans, Mice, Nude, Neoplasm Transplantation, Neoplasms, Stress, Physiological, Gene Expression Regulation, Neoplastic, Disease Progression, Gene Dosage, Cell Line, Tumor, Cell Proliferation, Mice, MCF-7 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
